governmentFilingsNewsغير مصنف

REFILE-FDA puts clinical hold on Seattle Genetics’ cancer drug after 4 deaths

Dec 27 (Reuters) – Seattle Genetics Inc said on
Tuesday that four people had died in trials testing its
experimental cancer drug, prompting the U.S. Food and Drug
Administration to impose a clinical…

اظهر المزيد

مقالات ذات صلة

شاهد أيضاً
إغلاق
زر الذهاب إلى الأعلى
إغلاق